Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4512)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (169)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (179)
½Å¾à°³¹ß (1306)
¾ÏÄ¡·á (856)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (105)
Á¤½ÅÁúȯ (88)
Á¦³×¸¯ ÀǾàǰ (116)
Á¦¾àȸ»çºÐ¼® (488)
󹿾à (128)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

°¨¿°Áúȯ ½ÃÀåÁ¶»çº¸°í¼­

°¨¿°Áúȯ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 319 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Global HIV/AIDS Testing Market 2010-2014
»ùÇÃ
»óǰÄÚµå :229558
¼¼°è HIV/AIDS °Ë»ç ½ÃÀå¿¡ ´ëÇØ 2010-2014³â ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ±× ¿¹Ãø, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦, ÁÖ¿ä º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Infiniti Research Limited
ÆäÀÌÁö¼ö Pages: 30
Future Infectious Disease Testing Market: Growth Opportunities, Business Strategies, Market Entry Barriers and Risks
»ùÇÃ
»óǰÄÚµå :228250
°¨¿°Áõ °Ë»ç(Infectious Disease Testing) ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, ±â±â, ½Ã¾à ŰƮ/°Ë»ç ÆÐ³Î, ¼Ò¸ðǰ, IT Á¦Ç°, º¸Á¶ Á¦Ç° µîÀÇ ÁÖ¿ä ±âȸ ºÐ¼®, ºÐ»êÇü °Ë»ç Á¦Ç° ¼³°è ±âÁØ Á¦¾È, °ø±Þ¾÷ü¿ë ´ëü »ç¾÷ È®´ë Àü·« Á¦½Ã, ÀáÀçÀûÀÎ ½ÃÀå ÁøÃâ À庮°ú À§Çè ºÐ¼® µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 950
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country
»ùÇÃ
»óǰÄÚµå :228248
¼¼°è °¢±¹ÀÇ °¨¿°Áõ(Infectious Disease) °Ë»ç ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, °¨¿°Áõ °Ë»ç¸¦ ½Ç½ÃÇϰí ÀÖ´Â ½Ã¼³¼ö, ÇâÈÄ 10³â°£ ±¹°¡º° °Ë»ç °Ç¼ö ¿¹Ãø°ú ¸ÅÃâ ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
»ùÇÃ
»óǰÄÚµå :228219
ºê¶óÁú, ·¯½Ã¾Æ, Àεµ, Áß±¹, ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÇ °¨¿°¸é¿ªÇÐ(Infectious Immunology) °ü·Ã Á¦Ç° ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, ±¹°¡ ¹× °¨¿°Áõ ºÎ¹®º° ¸ÅÃâ ½ÇÀû°ú ¿¹Ãø(¡­2017³â), À¯Åë°æ·Î ¹× ±â¾÷ ½ÃÀå Á¡À¯À², ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 135
Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
»ùÇÃ
»óǰÄÚµå :227787
¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ¹é½Å(Influenza Vaccine) ½ÃÀå ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø(¡­2015³â), Áö¿ª ¹× ±¹°¡, ÀÎÇ÷翣ÀÚÀÇ Á¾·ù, ÁÖ¿ä ¹é½Å ºê·£µå À¯Çüº° »ó¼¼ ºÐ¼®, °¢Á¾ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®, ÁÖ¿ä »ç¾÷ÀÚÀÇ ¸ÅÃâ ¹× ±â¾÷ ºÐ¼® µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,100
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Renub Research
ÆäÀÌÁö¼ö 80 Pages
Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market
»ùÇÃ
»óǰÄÚµå :227587
¹Ì±¹, À¯·´ 5°³±¹, ÀϺ»ÀÇ °£¿°(Hepatitis) ½ÃÀåÀ» Á¶»ç ´ë»óÀ¸·Î 2017³â±îÁöÀÇ Ä¡·á¹ý »ç¿ë µ¿Çâ, ¸ÅÃâ, °¡°Ý, ÃâÇÏ·®, Áö¿ªº° ÁÖ¿ä Ä¡·áÁ¦ ºÎ¹® ¿¹Ãø, ÁÖ¿ä ±â¾÷ÀÇ °æÀïÀû º¥Ä¡¸¶Å·, Àμö ÇÕº´, ¶óÀ̼¾½Ì °è¾à µî ¼¼°è ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â ¿äÀÎÀ» ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 114
Antiviral Therapeutics - technologies, markets and companies
»óǰÄÚµå :70939
°¢Á¾ Ç×¹ÙÀÌ·¯½º Ä¡·á ±â¼ú, ½ÃÀå µ¿Çâ, ±â¾÷ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
Hospital Acquired Bacterial Infections Market to 2017 - Niche Players are Most Active in R&D, Positioning Them as Potential Acquisition Targets for Big Pharma
»ùÇÃ
»óǰÄÚµå :227586
¼¼°èÀÇ º´¿ø³» ¼¼±Õ°¨¿°(HABI) ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎÀ» ºÐ¼®ÇßÀ¸¸ç, ¹Ì±¹, À¯·´ ÁÖ¿ä 5°³±¹, ÀϺ» ½ÃÀå ºÐ¼®, Ä¡·á ÀÌ¿ë ÆÐÅÏ, ¸ÅÃâ, °¡°Ý, 2017³â±îÁöÀÇ Àü¸Á, ÁÖ¿ä ±â¾÷, M&A µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 86
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity
»ùÇÃ
»óǰÄÚµå :226429
°èÀý¼º ÀÎÇ÷翣ÀÚ ¹é½Å ¿¬±¸ ÆÄÀÌÇÁ¶óÀο¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀÇ ÇâÈÄ µ¿Çâ, Áö¿ªº° µ¥ÀÌÅÍ, ¹ý±ÔÁ¦ ȯ°æ, °æÀï µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 156
»ùÇÃ
»óǰÄÚµå :226022
2010³â¡­2014³â°£ ¼¼°è HIV Ä¡·áÁ¦ ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¼ºÀå ¿äÀΰú °úÁ¦, ÁÖ¿ä º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Infiniti Research Limited
ÆäÀÌÁö¼ö Pages: 31
Emerging Blood Typing, Grouping and Infectious Disease Screening Tests and Companies Developing New Technologies
»ùÇÃ
»óǰÄÚµå :225015
Ç÷¾×Çü ÆÇÁ¤(Blood Typing, Grouping) ¹× °¨¿°Áõ ½ºÅ©¸®´× Å×½ºÆ®(Infectious Disease Screening Tests) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Ç÷¾×Çü ÆÇÁ¤ °Ë»ç¿Í NAT °Ë»ç¸¦ Æ÷ÇÔÇÑ °¨¿°Áõ ½ºÅ©¸®´× Å×½ºÆ®ÀÇ ÀÓ»óÀû ÀÇÀÇ¿Í ½ÃÀå ¼ö¿ä¿¡ ´ëÇÑ ºÐ¼®, Ç÷¾×ÀºÇàÀÇ ½Å±â¼ú°ú ½ÅÁ¦Ç°À» °³¹ß, ÆÇ¸ÅÇϰí ÀÖ´Â ±â¾÷ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Innovations in Molecular Diagnostics for Infectious Diseases
»ùÇÃ
»óǰÄÚµå :228156
½Å»ý ¹× º¯ÀÌ º´¿øÃ¼ ¹× »õ·Î¿î ºÐÀÚ ½ÃÇè ±â¼úÀ» ÀÇ·á °ü·Ã °¨¿°(ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °¨¿°, Ç÷¾× ¸Å°³ ¹ÙÀÌ·¯½º °¨¿°, È£Èí±â ¹ÙÀÌ·¯½º °¨¿° µî) ºÐ¾ßÀÇ ¿ì¼öÇÑ Áø´Ü Á¦Ç°¿¡ °áÇÕ½ÃŰ´Â ¹æ¹ýÀÌ µîÀåÇÏ°Ô µÇ¸é¼­, ºÐÀÚ Áø´Ü ±â¼ú°³¹ßÀÚ¿¡°Ô ÁÖ¾îÁö´Â ±âȸ¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,835
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Business Insights
ÆäÀÌÁö¼ö Pages: 168
Fungemia Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :196122
Áø±ÕÇ÷Áõ Ä¡·áÁ¦¿¡ °üÇÑ ÀÓ»ó½ÃÇè µ¿Çâ¿¡ ´ëÇØ ÀÓ»ó½ÃÇè ¼ö ¹× ÇÇÇèÀÚ¼ö, ´Ü°èº° ¹× »ó(Phase)º° »óȲ, À¯¸Á±â¾÷, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 67
Enterovirus Infections Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :196116
Àå³» ¹ÙÀÌ·¯½º °¨¿°Áõ(Enterobacteriaceae Infections) Ä¡·áÁ¦¿¡ °ü·ÃµÈ ÀÓ»ó½ÃÇè µ¿Çâ¿¡ ´ëÇØ ÀÓ»ó½ÃÇè °Ç¼ö ¹× ÇÇÇèÀÚ ¼ö, ´Ü°è(Phase)º°, »ó(Trial Status)º° »óȲ, À¯¸Á ±â¾÷, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 63
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :196107
°Å´ë¼¼Æ÷¹ÙÀÌ·¯½º(CMV: Cytomegalovirus) ¸Á¸·¿° Ä¡·áÁ¦¿¡ °ü·ÃµÈ ÀÓ»ó½ÃÇè µ¿Çâ¿¡ ´ëÇØ ÀÓ»ó½ÃÇè °Ç¼ö ¹× ÇÇÇèÀÚ ¼ö, ´Ü°è(Phase)º°, »ó(Trial Status)º° »óȲ, À¯¸Á ±â¾÷, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 53
Syphilis Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :175085
¸Åµ¶(Syphilis) Ä¡·áÁ¦¿¡ °üÇÑ ÀÓ»ó½ÃÇè µ¿ÇâÀ» Á¶»çÇϰí, ÀÓ»ó½ÃÇè ¼ö ¹× ÇÇÇèÀÚ ¼ö, ´Ü°èº° ¹× »óº° »óȲ, À¯¸Á ±â¾÷, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸, ÀÓ»ó½ÃÇèÀÇ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 60
Antibacterial Drugs: World Market Prospects 2012-2022
»ùÇÃ
»óǰÄÚµå :226947
Ç×»ýÁ¦(Antibacterial Drugs) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Àü¼¼°è ¹× ÁÖ¿ä °¢±¹À» ´ë»óÀ¸·Î 2022³â±îÁö ÇâÈÄ 10³â°£ÀÇ ¸ÅÃâ ¼ºÀå ¿¹Ãø, ÇöÀçÀÇ ÁÖ¿ä Á¦Ç° ¹× Á¦¾à Á¦Á¶¾÷ü µ¿Ç⠺м®, Ç×±Õ È¿°ú Çâ»óÀ» À§ÇÑ ½Å¾à °³¹ß ÇöȲÀ» ºÐ¼®ÇÑ ÃֽŠÁ¶»ç Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,642
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 167 Pages
Global Yersinia Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224858
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ¿©½Ã´Ï¾Æ(Yersinia) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ¿©½Ã´Ï¾ÆÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Vibrio Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224857
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ºñºê¸®¿À(Vibrio) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ºñºê¸®¿ÀÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Tuberculosis Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224856
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ °áÇÙ(Tuberculosis) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, °áÇÙÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Toxoplasmosis Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224855
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ Åå¼ÒÇö󽺸¶Áõ(Toxoplasmosis) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, Åå¼ÒÇö󽺸¶ÁõÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Syphilis Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224854
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ¸Åµ¶(Pseudomonas) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ¸Åµ¶ÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Streptococci Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224853
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ¿¬¼â±¸±Õ(Streptococci) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ¿¬¼â±¸±ÕÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Shigella Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224852
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ Àû¸®±Õ(Shigella) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, Àû¸®±ÕÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Septicemia Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224851
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ÆÐÇ÷Áõ(Septicemia) Áø´Ü °ü·Ã ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ÆÐÇ÷ÁõÀÇ Á¤ÀÇ, ¿ªÇÐ, º´ÀÎ, Áø´Ü°Ë»ç ±â¼úÀÇ Ãֽе¿Çâ, ÇâÈÄ 5-10³â°£ÀÇ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå ±Ô¸ð, ¸ÅÃâ, ½ÃÀå Á¡À¯À² µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·« ¹× Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö